Jarsix (Loratadine/Betamethasone) Tablets 5/0.25mg, 20 count

Category

Medications

Line

Antihistamines/Corticosteroids

Brand

Jarsix

Molecule

Loratadine/Betamethasone

Presentation

Tablets 5/0.25Mg With 20

Laboratory

Senosiain

Indications

Jarsix is indicated for the treatment of allergic diseases, such as seasonal and perennial allergic rhinitis, as well as for the management of symptoms associated with chronic urticaria. The combination of Loratadine, a second-generation antihistamine, and Betamethasone, a corticosteroid, allows for an effective therapeutic approach by relieving symptoms of itching, sneezing, runny nose, and skin rashes. This medication is used when additional control of inflammation and allergic symptoms that do not respond adequately to antihistamines alone is required.

Composition

Each tablet contains: Loratadine 5 mg and Betamethasone 0.25 mg. Excipients: Lactose, starch, microcrystalline cellulose, magnesium stearate, among others.

Contraindications

Jarsix is contraindicated in patients who are hypersensitive to Loratadine, Betamethasone, or any component of the formula. Its use is not recommended in patients with uncontrolled viral, bacterial, or fungal infections, as well as in those with a history of peptic ulcers or severe gastrointestinal diseases.

Precautions

Caution should be exercised in patients with liver or kidney diseases, as well as in those who are being treated with other medications that may interact with Loratadine or Betamethasone. Its use in pregnant or breastfeeding women should be evaluated by a doctor.

Storage

Store in a cool, dry place, at a temperature not exceeding 30 °C. Keep out of reach of children.

Consult your doctor.

Prescription required.